25F A randomized, double-blind, placebo-controlled trial investigated the effects of berberine in those who underwent coronary artery bypass grafting

Some had been accused of taking the easy way out. I think that there is kind of a stigma that its a cop-out, one participant said, that youre just taking the easy way out rather than doing it with diet and exercise like you should. Reflecting on the findings, de Vere Hunt shares, I expected perceived stigma to be present for people taking GLP-1 RA medications, but I was surprised by how strongly it still emerged in interviews. A particularly important finding, she added, was that many participants felt society viewed GLP-1 use differently depending on the reason: diabetes treatment was seen as legitimate, while obesity treatment was often framed as cheating. Biologically this doesnt make much sense, de Vere Hunt said, as obesity is also a chronic disease involving dysregulated hormonal and metabolic pathways with serious long-term health implications. Yet eligibility criteria, she said, can reinforce the misconception that people do not need medical support to treat obesity alone

We have the technology and expertise to provide you with the energy boost you need
Pramlintide (Symlin) is the short-acting amylin analog FDA-approved 2005 for adjunctive use with insulin in type 1 and insulin-treated type 2 diabetes
Researchers comparing mazdutide vs tirzepatide or retatrutide vs semaglutide should be aware that different peptide formulations may have unique metabolic effects when combined with additives
53% of millennials experience fewer or less painful periods with GLP-1s, higher than 28% of Gen Z